Facilitation of electroporative drug uptake and cell killing by electrosensitization

Journal of Cellular and Molecular Medicine

Volumn 17, Issue 1, 2013, Pages 154-159

  Pakhomova, Olga N ^a   Gregory, Betsy W ^a   Pakhomov, Andrei G ^a  

^a OLD DOMINION UNIVERSITY   (United States)

Author keywords

Ablation; Electric pulses; Electrochemotherapy; Electroporation; Membrane permeability

Indexed keywords

BLEOMYCIN; CYTOTOXIN; PROPIDIUM IODIDE;

ANIMAL; ARTICLE; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CHO CELL; CRICETULUS; DRUG EFFECT; ELECTROPORATION; EXPERIMENTAL MELANOMA; HAMSTER; METABOLISM; METHODOLOGY; MOUSE; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; BLEOMYCIN; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CHO CELLS; CRICETINAE; CRICETULUS; CYTOTOXINS; ELECTROPORATION; MELANOMA, EXPERIMENTAL; MICE; PROPIDIUM;

EID: 84873134654     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2012.01658.x     Document Type: Article

References (30)

1. Zimmermann U, Neil GA. Electromanipulation of cells. Boca Raton: CRC Press, 1996.
2. Rubinsky B, ed. Irreversible electroporation. Series in biomedical engineering. Berlin Heidelberg: Springer-Verlag, 2010.
3. Neumann E, Sowers AE, Jordan CA, eds. Electroporation and electrofusion in cell biology. New York: Plenum Press, 1989.
4. Pakhomov AG, Pakhomova ON. Nanopores: a distinct transmembrane passageway in electroporated cells. In: Pakhomov AG, Miklavcic D, Markov MS, eds. Advanced electroporation techniques in biology and medicine. Boca Raton: CRC Press, 2010:177-94.
5. Rubinsky J, Onik G, Mikus P, et al. Optimal parameters for the destruction of prostate cancer using irreversible electroporation. J Urol. 2008; 180: 2668-74.
6. Al-Sakere B, Andre F, Bernat C, et al. Tumor ablation with irreversible electroporation. PLoS ONE. 2007; 2: e1135.
7. Maor E, Ivorra A, Rubinsky B. Non thermal irreversible electroporation: novel technology for vascular smooth muscle cells ablation. PLoS ONE. 2009; 4: e4757.
8. Marty M, Sersa G, Garbay JR, et al. Electrochemotherapy - An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European standard operating procedures of electrochemotherapy) study. Eur J Cancer Suppl. 2006; 11: 3-13.
9. Sersa G, Miklavcic D, Cemazar M, et al. Electrochemotherapy in treatment of tumours. Eur J Surg Oncol. 2008; 34: 232-40.
10. Sersa G, Stabuc B, Cemazar M, et al. Electrochemotherapy with cisplatin: the systemic antitumour effectiveness of cisplatin can be potentiated locally by the application of electric pulses in the treatment of malignant melanoma skin metastases. Melanoma Res. 2000; 10: 381-5.
11. Breton M, Mir LM. Microsecond and nanosecond electric pulses in cancer treatments. Bioelectromagnetics. 2012; 33: 106-23.
12. Heller LC, Heller R. In vivo electroporation for gene therapy. Hum Gene Ther. 2006; 17: 890-7.
13. Andre FM, Gehl J, Sersa G, et al. Efficiency of high- and low-voltage pulse combinations for gene electrotransfer in muscle, liver, tumor, and skin. Hum Gene Ther. 2008; 19: 1261-71.
14. Escoffre JM, Portet T, Wasungu L, et al. What is (still not) known of the mechanism by which electroporation mediates gene transfer and expression in cells and tissues. Mol Biotechnol. 2009; 41: 286-95.
15. Faurie C, Rebersek M, Golzio M, et al. Electro-mediated gene transfer and expression are controlled by the life-time of DNA/membrane complex formation. J Gene Med. 2010; 12: 117-25.
16. Heller LC, Heller R. Electroporation gene therapy preclinical and clinical trials for melanoma. Curr Gene Ther. 2010; 10: 312-7.
17. Mir LM. Nucleic acids electrotransfer-based gene therapy (electrogenetherapy): past, current, and future. Mol Biotechnol. 2009; 43: 167-76.
18. Phillips M, Maor E, Rubinsky B. Nonthermal irreversible electroporation for tissue decellularization. J Biomech Eng. 2010; 132: 091003.
19. Pakhomova ON, Gregory BW, Khorokhorina VA, et al. Electroporation-induced electrosensitization. PLoS ONE. 2011; 6: e17100.
20. Mir LM, Banoun H, Paoletti C. Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: direct access to the cytosol. Exp Cell Res. 1988; 175: 15-25.
21. Mir LM, Glass LF, Sersa G, et al. Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer. 1998; 77: 2336-42.
22. Gothelf A, Mir LM, Gehl J. Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat Rev. 2003; 29: 371-87.
23. Zupanic A, Ribaric S, Miklavcic D. Increasing the repetition frequency of electric pulse delivery reduces unpleasant sensations that occur in electrochemotherapy. Neoplasma. 2007; 54: 246-50.
24. Ball C, Thomson KR, Kavnoudias H. Irreversible electroporation: a new challenge in "out of operating theater" anesthesia. Anesth Analg. 2010; 110: 1305-9.
25. Miklavcic D, Pucihar G, Pavlovec M, et al. The effect of high frequency electric pulses on muscle contractions and antitumor efficiency in vivo for a potential use in clinical electrochemotherapy. Bioelectrochemistry. 2005; 65: 121-8.
26. Pakhomov AG, Phinney A, Ashmore J, et al. Characterization of the cytotoxic effect of high-intensity, 10-ns duration electrical pulses. IEEE Trans Plasma Sci. 2004; 32: 1579-85.
27. Walker K 3rd, Pakhomova ON, Kolb J, et al. Oxygen enhances lethal effect of high-intensity, ultrashort electrical pulses. Bioelectromagnetics. 2006; 27: 221-5.
28. Ibey BL, Pakhomov AG, Gregory BW, et al. Selective cytotoxicity of intense nanosecond-duration electric pulses in mammalian cells. Biochim Biophys Acta. 2010; 1800: 1210-9.
29. Ibey BL, Roth CC, Pakhomov AG, et al. Dose-dependent thresholds of 10-ns electric pulse induced plasma membrane disruption and cytotoxicity in multiple cell lines. PLoS ONE. 2011; 6: e15642.
30. Kennedy SM, Ji Z, Hedstrom JC, et al. Quantification of electroporative uptake kinetics and electric field heterogeneity effects in cells. Biophys J. 2008; 94: 5018-27.